8-bromo-N-(1-prop-2-ynylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-bromo-N-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;3-chloroprop-1-yne;8-[3-(4-ethylpyrazol-1-yl)-3-(isocyanomethyl)azetidin-1-yl]-N-[1-[[1-[1-(oxetan-3-yl)piperidin-4-yl]triazol-4-yl]methyl]pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine
C54H55Br2ClN26O — CID 161417928
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-bromo-N-(1-prop-2-ynylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-bromo-N-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;3-chloroprop-1-yne;8-[3-(4-ethylpyrazol-1-yl)-3-(isocyanomethyl)azetidin-1-yl]-N-[1-[[1-[1-(oxetan-3-yl)piperidin-4-yl]triazol-4-yl]methyl]pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine
8-bromo-N-(1-prop-2-ynylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-bromo-N-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;3-chloroprop-1-yne;8-[3-(4-ethylpyrazol-1-yl)-3-(isocyanomethyl)azetidin-1-yl]-N-[1-[[1-[1-(oxetan-3-yl)piperidin-4-yl]triazol-4-yl]methyl]pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine (PubChem CID 161417928) has the molecular formula C54H55Br2ClN26O and a molecular weight of 1279.48 g/mol. Its IUPAC name is 8-bromo-N-(1-prop-2-ynylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-bromo-N-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;3-chloroprop-1-yne;8-[3-(4-ethylpyrazol-1-yl)-3-(isocyanomethyl)azetidin-1-yl]-N-[1-[[1-[1-(oxetan-3-yl)piperidin-4-yl]triazol-4-yl]methyl]pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine.
Molecular Properties
| Compound Name | 8-bromo-N-(1-prop-2-ynylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-bromo-N-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;3-chloroprop-1-yne;8-[3-(4-ethylpyrazol-1-yl)-3-(isocyanomethyl)azetidin-1-yl]-N-[1-[[1-[1-(oxetan-3-yl)piperidin-4-yl]triazol-4-yl]methyl]pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine |
|---|---|
| PubChem CID | 161417928 |
| Molecular Formula | C54H55Br2ClN26O |
| Molecular Weight | 1279.48 g/mol |
| Exact Mass | 1276.31 |
| IUPAC Name | 8-bromo-N-(1-prop-2-ynylpyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-bromo-N-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;3-chloroprop-1-yne;8-[3-(4-ethylpyrazol-1-yl)-3-(isocyanomethyl)azetidin-1-yl]-N-[1-[[1-[1-(oxetan-3-yl)piperidin-4-yl]triazol-4-yl]methyl]pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine |
| SMILES | Brc1cccn2nc(Nc3cn[nH]c3)nc12.C#CCCl.C#CCn1cc(Nc2nc3c(Br)cccn3n2)cn1.[C-]#[N+]CC1(n2cc(CC)cn2)CN(c2cccn3nc(Nc4cnn(Cc5cn(C6CCN(C7COC7)CC6)nn5)c4)nc23)C1 |
| InChI | InChI=1S/C30H36N14O.C12H9BrN6.C9H7BrN6.C3H3Cl/c1-3-22-11-33-44(13-22)30(19-31-2)20-40(21-30)27-5-4-8-42-28(27)35-29(37-42)34-23-12-32-41(14-23)15-24-16-43(38-36-24)25-6-9-39(10-7-25)26-17-45-18-26;1-2-5-18-8-9(7-14-18)15-12-16-11-10(13)4-3-6-19(11)17-12;10-7-2-1-3-16-8(7)14-9(15-16)13-6-4-11-12-5-6;1-2-3-4/h4-5,8,11-14,16,25-26H,3,6-7,9-10,15,17-21H2,1H3,(H,34,37);1,3-4,6-8H,5H2,(H,15,17);1-5H,(H,11,12)(H,13,15);1H,3H2 |
| InChIKey | VWIHOYKRVTUJBI-UHFFFAOYSA-N |
| XLogP | 7.12 |
| TPSA | 259.58 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 84 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1279.48 |
| LogP ≤ 5 | 7.12 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 25 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161417928 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.